The Rakesh Jhunjhunwala entity--RARE Enterprises, sold 15.85 lakh shares or a 1.3 percent stake in Exicom Tele Systems, valued at Rs 55.25 crore.
Concord Biotech's financial landscape has undergone notable shifts, with operational margins stabilising around 40-42% in 2023.
Over the past one year, the net worth of his portfolio surged 53 percent to Rs 38,885 crore by the conclusion of the June 2023 quarter as compared with Rs 25,397 crore in June 2022.